Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells
Choline, an organic cation, is one of the biofactors that play an important role in the structure and the function of biological membranes, and it is essential for the synthesis of phospholipids. Choline positron emission tomography-computed tomography (PET/CT) provides useful information for the im...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/15/5190 |
_version_ | 1797561662668013568 |
---|---|
author | Kaho Hirai Saiichiro Watanabe Nozomi Nishijima Kaoru Shibata Akane Hase Tsuyoshi Yamanaka Masato Inazu |
author_facet | Kaho Hirai Saiichiro Watanabe Nozomi Nishijima Kaoru Shibata Akane Hase Tsuyoshi Yamanaka Masato Inazu |
author_sort | Kaho Hirai |
collection | DOAJ |
description | Choline, an organic cation, is one of the biofactors that play an important role in the structure and the function of biological membranes, and it is essential for the synthesis of phospholipids. Choline positron emission tomography-computed tomography (PET/CT) provides useful information for the imaging diagnosis of cancers, and increased choline accumulation has been identified in a variety of tumors. However, the molecular mechanisms of choline uptake and choline transporters in pancreatic cancer have not been elucidated. Here, we examined molecular and functional analyses of choline transporters in human pancreatic-cancer cell line MIA PaCa-2 and the elucidation of the action mechanism behind the antitumor effect of novel choline-transporter-like protein 1 (CTL1) inhibitors, Amb4269951 and its derivative Amb4269675. CTL1 and CTL2 mRNAs were highly expressed in MIA PaCa-2 cells, and CTL1 and CTL2 proteins were localized in the plasma membrane and the intracellular compartments, respectively. Choline uptake was characterized by Na<sup>+</sup>-independence, a single-uptake mechanism, and inhibition by choline-uptake inhibitor HC-3, similar to the function of CTL1. These results suggest that the uptake of extracellular choline in MIA PaCa-2 cells is mediated by CTL1. Choline deficiency and HC-3 treatment inhibited cell viability and increased caspase 3/7 activity, suggesting that the inhibition of CTL1 function, which is responsible for choline transport, leads to apoptosis-induced cell death. Both Amb4269951 and Amb4269675 inhibited choline uptake and cell viability and increased caspase-3/7 activity. Ceramide, which is increased by inhibiting choline uptake, also inhibited cell survival and increased caspase-3/7 activity. Lastly, both Amb4269951 and Amb4269675 significantly inhibited tumor growth in a mouse-xenograft model without any adverse effects such as weight loss. CTL1 is a target molecule for the treatment of pancreatic cancer, and its inhibitors Amb4269951 and Amb4269675 are novel lead compounds. |
first_indexed | 2024-03-10T18:18:05Z |
format | Article |
id | doaj.art-a40905ec43d5457289d5b0a83eaf7ec2 |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-10T18:18:05Z |
publishDate | 2020-07-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-a40905ec43d5457289d5b0a83eaf7ec22023-11-20T07:33:59ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-07-012115519010.3390/ijms21155190Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer CellsKaho Hirai0Saiichiro Watanabe1Nozomi Nishijima2Kaoru Shibata3Akane Hase4Tsuyoshi Yamanaka5Masato Inazu6Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanDepartment of Molecular Preventive Medicine, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanCholine, an organic cation, is one of the biofactors that play an important role in the structure and the function of biological membranes, and it is essential for the synthesis of phospholipids. Choline positron emission tomography-computed tomography (PET/CT) provides useful information for the imaging diagnosis of cancers, and increased choline accumulation has been identified in a variety of tumors. However, the molecular mechanisms of choline uptake and choline transporters in pancreatic cancer have not been elucidated. Here, we examined molecular and functional analyses of choline transporters in human pancreatic-cancer cell line MIA PaCa-2 and the elucidation of the action mechanism behind the antitumor effect of novel choline-transporter-like protein 1 (CTL1) inhibitors, Amb4269951 and its derivative Amb4269675. CTL1 and CTL2 mRNAs were highly expressed in MIA PaCa-2 cells, and CTL1 and CTL2 proteins were localized in the plasma membrane and the intracellular compartments, respectively. Choline uptake was characterized by Na<sup>+</sup>-independence, a single-uptake mechanism, and inhibition by choline-uptake inhibitor HC-3, similar to the function of CTL1. These results suggest that the uptake of extracellular choline in MIA PaCa-2 cells is mediated by CTL1. Choline deficiency and HC-3 treatment inhibited cell viability and increased caspase 3/7 activity, suggesting that the inhibition of CTL1 function, which is responsible for choline transport, leads to apoptosis-induced cell death. Both Amb4269951 and Amb4269675 inhibited choline uptake and cell viability and increased caspase-3/7 activity. Ceramide, which is increased by inhibiting choline uptake, also inhibited cell survival and increased caspase-3/7 activity. Lastly, both Amb4269951 and Amb4269675 significantly inhibited tumor growth in a mouse-xenograft model without any adverse effects such as weight loss. CTL1 is a target molecule for the treatment of pancreatic cancer, and its inhibitors Amb4269951 and Amb4269675 are novel lead compounds.https://www.mdpi.com/1422-0067/21/15/5190pancreatic cancertransportercholinecholine transporter-like proteinceramidecaspase |
spellingShingle | Kaho Hirai Saiichiro Watanabe Nozomi Nishijima Kaoru Shibata Akane Hase Tsuyoshi Yamanaka Masato Inazu Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells International Journal of Molecular Sciences pancreatic cancer transporter choline choline transporter-like protein ceramide caspase |
title | Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells |
title_full | Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells |
title_fullStr | Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells |
title_full_unstemmed | Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells |
title_short | Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells |
title_sort | molecular and functional analysis of choline transporters and antitumor effects of choline transporter like protein 1 inhibitors in human pancreatic cancer cells |
topic | pancreatic cancer transporter choline choline transporter-like protein ceramide caspase |
url | https://www.mdpi.com/1422-0067/21/15/5190 |
work_keys_str_mv | AT kahohirai molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells AT saiichirowatanabe molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells AT nozominishijima molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells AT kaorushibata molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells AT akanehase molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells AT tsuyoshiyamanaka molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells AT masatoinazu molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells |